News
The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.
The lack of effect on QoL and oxygen consumption help cement the idea that the disease isn’t the same as obstructive HCM.
Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...
Numerous components beyond length of sleep have important ties to cardiometabolic disease and related risk factors.
For all the different subpopulations, having a CAC score > 100 strongly predicted risk of CV death (P < 0.007). Yet the ...
Added information from the assays could guide care, especially for intermediate-risk patients on the cusp of initiating ...
This month: shorter recovery after TAVI, Down syndrome CV insights, the benefits of brisker walking, and more.
There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.
The ABCVM wanted to certify cardiologists outside of ABIM, but the recent denial doesn’t mean their efforts have stopped.
CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...
For every 100,000 runners who complete the full 42.2 km distance, there will be one cardiac arrest, new data show.
The dynamic field of advanced heart failure, and helping these patients live comfortably, has inspired this fellow.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results